GALECTIN THERAPEUTICS INC (GALT) — institutional ownership
111 funds reported holding GALECTIN THERAPEUTICS INC in their latest 13F filings, worth $88.4M in total (CUSIP 363225202).
Largest holders
- BlackRock, Inc. (BLK) — $13.9M
- VANGUARD CAPITAL MANAGEMENT LLC — $10.1M
- VANGUARD GROUP INC — $9.52M
- GEODE CAPITAL MANAGEMENT, LLC — $6.07M
- OSAIC HOLDINGS, INC. — $5.59M
- MARSHALL WACE, LLP — $3.86M
- GREAT POINT PARTNERS LLC — $3.71M
- Wealthspire Advisors, LLC — $3.35M
- STATE STREET CORP (STT, STT-PG) — $2.63M
- CITADEL ADVISORS LLC — $2.50M
Famous investors holding it
- Ken Griffin portfolio (Citadel Advisors)
- Two Sigma portfolio (Two Sigma Investments)
- Renaissance Technologies portfolio (Renaissance Technologies)
- Izzy Englander portfolio (Millennium Management)
Insider buying and selling at GALECTIN THERAPEUTICS INC
Who owns the most GALT stock?
The largest institutional holders in the latest 13F filings are BlackRock, Inc. (BLK) ($13.9M), VANGUARD CAPITAL MANAGEMENT LLC ($10.1M), VANGUARD GROUP INC ($9.52M).
How many funds own GALT?
111 funds reported holding it, worth $88.4M in total.